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ABSTRACT 
 
 
Pharmaceuticals and Personal Care Products (PPCP) in surface waters is a worldwide 
concern. Effluent from waste water treatment plants have tested positive for PPCP. 
Method development for a liquid chromatographic method was derived using columns 
with fused core technology.  Analysis of spiked samples as direct injection and after solid 
phase extraction indicated detection of acetaminophen, caffeine, bisphenol-A and triclo-
san.  Confirmation of acetaminophen, caffeine, bisphenol-A and triclosan was achieved 
using Agilent 1100 HPLC with Agilent MST Trap XCT.  Solid phase extraction using 
Oasis HLB indicated reproducibility at 0.05ppm.  
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CHAPTER 1 INTRODUCTORY 
 
Pharmaceutical and Personal Care Products (PPCP) enter the water system 
through human disposal and waste.  PPCPs targeted in quantitative and qualitative studies 
are antibiotics, antifungals, analgesics, antihistamines, disinfectants, UV-filters (sun-
screens), hormones and fragrances. PPCPs that are water soluble can be detected in the 
surface water downstream and from the effluent of wastewater treatment plants (WWTP) 
(1-3).  PPCPs contamination is a worldwide concern. In the United Kingdom, sexual dis-
ruption in wild fish was linked to estrogenic constituents of sewage effluents (4).  Waste 
water, surface water and fish tested positive for UV filters (sunscreens) in Switzerland 
(5). Galaxolide and tonalide, synthetic musk fragrances used in cosmetics and detergents, 
were detected in fish collected from effluent dominated streams in Chicago Illinois, Dal-
las Texas, Orland Florida, Phoenix Arizona, and West Chester Pennsylvania (6). Early 
studies in Canada indicated a presence of Bisphenol-A (BPA) in the effluent of WWTPs 
(7).  Although BPA is not PPCPs, the chemical was used in the manufacturer of many 
plastic containers used by consumers, including baby bottles.  BPA is consider an endo-
crine disruptor compound and has the potential to be toxic to aquatic life (7).   
The Environmental Protection Agency (EPA), the United States governing agen-
cy, regulates the treatment of sewage and waste water.  Effluents from local WWTPs 
should meet EPA’s specification on contaminants before it is returned to the ecology sys-
tem.   Currently the EPA does not have regulations for these contaminants and therefore 
does not have an official method listed in 40 CFR 136 (8).  Although the EPA does not 
have a method published in 40 CFR 136, it does have two methods available for general 
use.  Method 1694:  Pharmaceuticals and Personal Care Products in water, Soil, Sediment 
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and Biosolids by HPLC/MS/MS (December 2007), can be used to analyze for 74 PPCPs 
(9). Method 1698:  Steroids and Hormones in Water, Soil, Sediment and Biosolids by 
HRGC/HRMS (December 2007), can be used to analyze for 27 steroids and hormones 
(10).  Not all PPCP effects on aquatic life have been studied and as a result ambient water 
quality criteria and aquatic life criteria have not been established (11), this could be one 
potential reason for Method 1694 and Method 1698 omission from 40 CFR 136. 
PPCPs in surface water and effluent of WWTPs in previous studies have been de-
tected at very low levels, µg/L, (1, 3, 5).  Analysis requires sensitive instrumentation and 
sample preparation that incorporates concentration procedures.  EPA’s Method 1694 re-
quires the use of high pressure liquid chromatography with tandem mass spectrometry 
(HPLC/MS/MS), with complex sample preparation using solid phase extraction to con-
centrate the PPCPs, allowing them to be detected.  
The focus of this research is to develop a procedure that can detect PPCPs in wa-
ter and surface water with the instrumentation available at Governors State University.   
Due to the large number of PPCPs on the market, this project was limited to four 
PPCPs listed in Table 1. 
Table 1: PPCPs  
(12) (12) 
(12) 
(12) 
Acetaminophen Bisphenol A Caffeine Triclosan  
Molecular weight 
151.16  
Molecular weight 
228.29 
Molecular 
weight 194.19 
Molecular weight 
289.54 
CAS# 103-90-2 CAS# 80-05-7 CAS# 58-08-2 CAS# 3380-34-5 
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Acetaminophen is an analgesic found in many Over the Counter (OTC) products.  
It is the active pharmaceutical ingredient (API) in Tylenol (13). Caffeine a stimulant is 
the API in some analgesic OTC.  Caffeine can be found in coffee, tea, carbonated bever-
ages, and energy drinks. Triclosan is an antibacterial agent that can be found in many 
consumer products, clothing, furniture, toys, body washes, toothpaste and mouth washes. 
Bisphenol A is used to manufacture polycarbonate plastic and epoxy resins.  The plastics 
and resins are used in a wide variety of products, digital media, automobiles, reusable 
water bottles, drink containers, epoxy lining of canned foods and beverages to name a 
few.  These four PPCPs1 were chosen due to their abundance on the market. 
CHAPTER 2 EQUIPMENT REAGENTS 
 
 Acetaminophen, caffeine, bisphenol-A and triclosan (Irgasan) high purity stand-
ards (≥ 99.0%) were purchased from Sigma Aldrich.  Acetonitrile and methanol (HPLC 
grade or better) from Burdick & Jackson and Fisher Scientific were used. Deionized Wa-
ter was supplied from Governors State University (University Park IL) and Blistex Inc 
(Oak Brook IL). High Purity Water from Burdick & Jackson was used for this project.  
 During the project, HPLC columns with an octadecyl silica (C-18) stationary 
phase were utilized.  Supleco Ascentis Express fused core columns with 5µm particle 
size, 150mm x4.6mm (A-1)2 and 100mm x 2.1mm (A-2)3, purchased from Sigma Aldrich 
were used.  Kinetex fused core with 2.6µm particle size, 100mm x 4.6mm (K-1)4 and Lu-
                                                     
1 For this paper Bisphenol-A will be included as a PPCP. 
2 Column used at Blistex Inc (Oak Brook IL) 
3 Column used at Governors State Univeristy 
4 Column used at Blistex Inc (Oak Brook IL) 
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na C18 (2)5 porous 5µm particle size 150mm x 4.6mm (L-1), from Phenomenex were uti-
lized in this project.  
 Instruments used during this project were from two sources.  Agilent 1260 HPLC 
equipped with a photodiode array detector (PDA) (AG-1) and a hyphenated LC/MS, 
HP1100 HPLC system with a PDA detector coupled with an Agilent MST Trap XCT 
(AG-2) were used Governors State University.  PerkinElmer’s Flexar with PDA (PE-1) 
was utilized at Blistex Inc. 
 Samples that employed solid phase extraction employed the Resprep C18 
1mL/100mg cartridges from Restek and the Oasis HLB 30µm particle size 30mg sorbent 
Vac/RD 20cc cartridges from Waters.  During the study a 20 position Extraction Mani-
fold, 16mm x 100mm tubes, from Waters was employed with the Oasis HLB solid phase 
extraction cartridges. 
CHAPTER 3 RESEARCH EXPERIMENTATION 
 
 A mixed stock solution and individual stock solutions containing 500ppm of each 
of the four PPCPs were prepared.   Initially, acetonitrile was used to make all the dilu-
tions.  The solutions were analyzed using the gradient table outlined in Table 2.  
Table 2:  Preliminary Parameters 
Time % Acetonitrile % Water 
0-0.5 minutes 10% 90% 
0.5-5.5 minutes Ramp up 90% Ramp down 10% 
5.5-13.5 minutes 90% 10% 
13.5-18.5 minutes (equilibrate) 10% 90% 
 
                                                     
5 Column used at Blistex Inc (Oak Brook IL) 
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The analysis included injections of the 500ppm PPCP mix, and injections of the individu-
al PPCP stocks, deionized water, and acetonitrile shown in Figures2-8. Solutions of 
50ppm PPCP Mix were prepared from the 500ppm PPCP mix(acetonitrile) using 50/50 mix-
ture of acetonitrile/deionized water, methanol, and deionized water, Figures 9-11. 
 A PPCP mix solutions at concentrations of 0.5, 1, 5 and 10ppm were prepared 
using deionized water as the final dilutions. These solutions were analyzed on columns 
K-1 and A-1.  The instrument parameters are listed in Table 3. The solutions were inject-
ed in triplicate on each column.  Figure 12 and 13 indicate a small shift in the retention 
times of the PPCPs. 
Table 3: Instrument Parameters Kinetex (K-1) and Ascentis (A-1) Columns  
Instrument PE-1 (PerkinElmer Flexar with PDA) 
Column K-1 Kinetex 2.6µm 100mm X 4.6mm 
A-1 Ascentis 5µm 150mm X 4.6mm 
Wavelength 230nm and 205nm 
Flow 1.0mL/min 
Injection Volume 75µL 
Mobile Phase 10% Acetonitrile/90% Deionized Water (0.5 minutes) 
5 minute ramp to 90% Acetonitrile/10%Deionized Water  
90% Acetonitrile/Deionized Water (5 minutes) 
5 minute Equilibration at 10% Acetonitrile/90% Deionized Water 
 
A second set of PPCP Mix solutions were prepared, 0.02, 0.05, 0.1, 0.5, 1, and 5ppm, 
with deionized water as the final solvent. Analysis of the second set of PPCP Mix solu-
tions was conducted on instrument AG-1 with column A-2.  The instrument parameters 
are outlined in Table 4. Figures 14 and 15 shows the difference between the 0.5ppm 
PPCP mix and 0.2ppm PPCP Mix solutions, at injection volume of 30µL. Figure 16 
shows the chromatogram from 0.02ppm PPCP Mix solution at an injection volume of 95 
µL. 
 
 Page 12 of 25 
 
Table 4:  A-2 Instrument Parameters 
Instrument AG-1 (Agilent 1260 with PDA) 
Column A-2  Ascentis 5µm 100mm X 2.1mm 
Wavelength 230nm 
Flow 0.5mL/min 
Injection Volume 30µL, 95µL 
Mobile Phase 5% Acetonitrile/95% Deionized Water (0.5 minutes) 
5 minute ramp to 90% Acetonitrile/10%Deionized Water  
90% Acetonitrile/Deionized Water (5 minutes) 
5 minute Equilibration at 5% Acetonitrile/95% Deionized Water 
 
Solid phase extractions were conducted on PPCP mix spiked deionized water so-
lutions (Table 5). The solid phase extraction using the Restek Resprep C18 cartridges was 
conducted using the flow chart in Figure 1.  The reconstituted solutions were analyzed 
according to Table 4 with 95µL injection volume and the detector programmed to collect 
data from 230nm, 235nm, 240nm, 254nm, 273nm, and 280nm. 
Table 5: Solutions for Solid Phase Extraction 
Solution Total Volume 
0.001ppm 100.0mL 
0.005ppm 10.0mL 
0.002ppm 10.0ml 
0.01ppm 10.0mL 
0.25ppm 10.0mL 
 
Figure 1: Restek Resprep SPE Procedure Flowchart 
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 Solid phase extractions were conducted on 100.0mL of spiked deionized water at 
0.005ppm PPCP mix, triplicate preparations, and at 0.05ppm PPCP mix, duplicate prepa-
rations.  Deionized water was used as a blank.  This extraction process employed the Wa-
ters’ Oasis HLB cartridges.  The Oasis HLB extraction process employed a 5% methanol 
wash at 5mL/min before the elution of the sample in the procedure outlined in Figure 1.  
The analysis was conducted using Instrument AG-2 following the parameters outlined in 
Table 6. 
Table 6: Analysis Parameters for Oasis HLB Extraction 
Instrument AG-2 (Agilent 1100- PDA/ Agilent MST Trap XCT) 
Column A-2  Ascentis 5µm 100mm X 2.1mm 
Wavelength 230nm, 235nm, 254nm, 273nm, 280nm 
Flow 0.5mL/min 
Injection Volume 30µL, 95µL 
Mobile Phase 5% Acetonitrile/95% Deionized Water (0.5 minutes) 
5 minute ramp to 90% Acetonitrile/10%Deionized Water  
90% Acetonitrile/Deionized Water (5 minutes) 
5 minute Equilibration at 5% Acetonitrile/95% Deionized Water 
Nebulizer 40psi 
Dry Gas 8mL/min 
Dry Temperature 300°C 
Mode Positive and Negative 
 
Figure 2: 500ppm PPCP Mix  
 
Instrument PE-1, Column A-1, flow 1.0mL/min wavelength 230nm, 10µL injection volume. 
Figure 3: 500ppm Acetaminophen 
 
Instrument PE-1, Column A-1, flow 1.0mL/min wavelength 230nm, 10µL injection volume. 
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Figure 4: 500ppm Caffeine 
 
Instrument PE-1, Column A-1, flow 1.0mL/min wavelength 230nm, 10µL injection volume. 
Figure 5: Overlay of 500ppm Mix and 500ppm Bisphenol-A 
 
Instrument PE-1, Column A-1, flow 1.0mL/min wavelength 230nm, 10µL injection volume. 
Figure 6:  Overlay of 500ppm Mix and 500ppm Triclosan 
 
Instrument PE-1, Column A-1, flow 1.0mL/min wavelength 230nm, 10µL injection volume. 
Figure 7:  Overlay of 500ppm Mix and Acetonitrile 
 
Instrument PE-1, Column A-1, flow 1.0mL/min wavelength 230nm, 10µL injection volume. 
Figure 8: Overlay of 500ppm Mix and Deionized Water 
 
Instrument PE-1, Column A-1, flow 1.0mL/min wavelength 230nm, 10µL injection volume. 
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Figure 9: 50ppm PPCP Mix With 50/50 Acetonitrile / Deionized Water 
Instrument PE-1, Column A-1, flow 1.0mL/min wavelength 230nm, 10µL injection volume. 
Figure 10: 50ppm PPCP Mix with Methanol 
 
Instrument PE-1, Column A-1, flow 1.0mL/min wavelength 230nm, 10µL injection volume. 
Figure 11: 50ppm PPCP Mix with Deionized Water 
 
Instrument PE-1, Column A-1, flow 1.0mL/min wavelength 230nm, 10µL injection volume. 
Figure 12:  0.5ppm PPCP Mix with Kinetex (K-1) Column 
 
Instrument PE-1, Column K-1, flow 1.0mL/min wavelength 230nm, 75µL injection volume 
Figure 13: 0.5ppm PPCP Mix with Ascentis (A-1) Column 
 
Instrument PE-1, Column A-1, flow 1.0mL/min wavelength 230nm, 75µL injection volume. 
 
 
0.00
100.00
200.00
300.00
400.00
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0
0.00
100.00
200.00
300.00
400.00
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0
0.00
100.00
200.00
300.00
400.00
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0
A
ce
ta
m
C
af
fe
in
e
B
is
ph
en
Tr
ic
lo
sa
0.00
20.00
40.00
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5 11.0 11.5 12.0 12.5 13.0 13.5 14.0 14.5 15.0
A
ce
ta
m
C
af
fe
in
e
B
is
ph
en
Tr
ic
lo
sa
0.00
20.00
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5 11.0 11.5 12.0 12.5 13.0 13.5 14.0 14.5 15.0
 Page 16 of 25 
 
Figure 14:  0.5ppm PPCP Mix on AG-1 with Column A-2 30 µL 
 
Instrument AG-1, Column A-2, flow 0.5mL/min wavelength 230nm, 30µL injection volume. 
Figure 15: 0.2ppm PPCP Mix on AG-1 with Column A-2 30 µL 
 
Instrument AG-1, Column A-2, flow 0.5mL/min wavelength 230nm, 30µL injection volume. 
 
Figure 16: 0.02ppm PPCP Mix on AG-1 with Column A-2 95 µL 
 
Instrument AG-1, Column A-2, flow 0.5mL/min wavelength 230nm, 30µL injection volume. 
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CHAPTER 4 RESULTS 
 
 Analysis conducted on instrument PE-1 with columns K-1 and A-1 indicated a 
separation method that can be used for detection and quantitation.  Precision was prelimi-
nary determined by injected each solution in triplicate.  The % Relative Standard Devia-
tion (%RSD) using the K-1 column (Table 3 parameters), yielded %RSD ≤ 6% for the 
0.5ppm PPCP mix and %RSD  ≤ 3% for 1, 5 and 10ppm PPCP mix at 230nm and 
205nm.  The A-1 column using Table 3 parameters yielded % RSD ≤ 8% for the 0.5ppm 
PPCP mix at 230nm and %RSD ≤ 4% at 205nm.  The %RSD were ≤ 4% for 1, 5 and 
10ppm PPCP mix at 230nm and 205nm.  Linearity was determined by the R-square val-
ues using the concentrations versus the average area response (n=3). PerkinElmer chro-
matographic software, TotalChrom was employed to determine the linearity for K-1 and 
A-1 at 230nm and 205nm.  All four PPCP had a linear response from 0.5 to 10ppm, with 
r-squares ≥ 0.990.   A 5ppm solution was used to determine the accuracy for the K-1 and 
A-1 columns at 230nm and 205nm.  At 230nm, recoveries for the analytes were within 
100% ± 3%, both columns and at 205nm recoveries for the analytes were within 100% ± 
10%. 
   Analysis conducted on instrument AG-1 with column A-2 was conducted at 
30uL and at 95uL (Table 4 parameters).  PPCP mix solution at 0.2, 0.5, 1 and 5ppm ana-
lyzed with a 30uL injection. Precision was determined on duplicate injections of 0.2, 0.5 
and 1ppm solutions and yielded %RSD ≤ 2.0%.  Linearity was determined by calculating 
the R-square values using concentrations versus average area responses (n=2)6.  All four 
PPCPs had a linear response from 0.2 to 5ppm with r-squares ≥ 0.9990.   
                                                     
6 Data for 5ppm standard was from a singular injection due to instrument/software error. 
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 Additional analysis was conducted on PPCP mixes at 0.02, 0.05, 1 and 5 ppm us-
ing parameters listed in Table 4 with 95uL injection volume at 230nm.  Precision was 
determined on duplicate injections of 0.2, 0.05, and 5ppm solutions and yielded %RSD ≤ 
2.0% for all acetaminophen, caffeine and triclosan.  Bisphenol-A precision for the 
0.05ppm solution was 12%    Linearity was determined by calculating the R-square val-
ues using concentrations versus area responses. All four PPCPs had a linear response 
from 0.02ppm to 5ppm ≥ 0.9999.  Recoveries of the duplicate injections of 0.05 and 
5ppm solutions were within 100% ± 15%. Recovery of caffeine at 0.02ppm was 72%. 
 Recoveries of the spiked deionized water samples using Restek Resprep C18 solid 
phase extraction ranged from 160% to 45% for caffeine, bisphenol-A and triclosan (Table 
7).  Acetaminophen was detected in the 0.25ppm (250ng/mL) solution with a 19% recov-
ery. 
Table 7: Restek Resprep C18 SPE Results 
Solution 
ID 
Acetaminophen 
Results 
%Recovery 
Caffeine 
Results 
%Recovery 
Bisphenol-A 
Results 
%Recovery 
Triclosan 
Results 
%Recovery 
1 ng/mL 
(0.001ppm) 
No peak detected 1.14 ng/mL 
114% 
2.63 ng/mL 
259% 
0.45 ng/mL 
45% 
2 ng/mL 
(0.002ppm 
No peak detected 2.51 ng/mL 
128% 
3.22 ng/mL 
159% 
2.08 ng/mL 
105% 
5 ng/mL 
(0.005ppm) 
No peak detected 6.02 ng/mL 
122% 
7.91 ng/mL 
156% 
5.48 ng/mL 
110% 
10 ng/mL 
(0.01ppm) 
No peak detected 9.24 ng/mL 
93% 
11.6 ng/mL 
114% 
6.76 ng/mL 
68% 
250 ng/mL 
(0.25ppm) 
47.8 ng/mL 
19% 
231 ng/mL 
94% 
239 ng/mL 
94% 
117 ng/mL 
47% 
 
 Oasis HLB solid phase extraction recoveries were reproducible for the 0.05ppm 
PPCP mix spiked deionized water samples, Table 8.  The 0.0005ppm PPCP analysis 
yielded results that were inconclusive, Table 8. 
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  Table 8: Oasis HLB SPE Results 
Solution 
ID 
Acetaminophen 
Results7 
%Recovery 
Caffeine 
Results7 
%Recovery 
Bisphenol-A 
Results7 
%Recovery 
Triclosan 
Results7 
%Recovery 
0.5 ng/mL 
(A) 
(0.0005ppm) 
No peak detected 0.391 ng/mL 
79%% 
45.1 ng/mL 
> 200% 
0.517 ng/mL 
102% 
0.5 ng/mL 
(B) 
(0.0005ppm 
2.60 ng/mL 
> 200% 
23.2 ng/mL 
> 200% 
33.0 ng/mL 
> 200% 
13.8 ng/mL 
> 200% 
0.5 ng/mL 
(C) 
(0.0005ppm) 
No peak detected 0.164 ng/mL 
33% 
0.471 ng/mL 
92% 
0.149 ng/mL 
30% 
50 ng/mL 
(0.05ppm) 
9.57 ng/mL 
19% 
47.6 ng/mL 
96% 
47.6 ng/mL 
93% 
40.4 ng/mL 
80% 
50 ng/mL 
(0.05ppm) 
9.13 ng/mL 
18% 
45.9 ng/mL 
92% 
46.2 ng/mL 
90% 
43.4 ng/mL 
86% 
  
CHAPTER 5 DISCUSSION 
 
 Preliminary analysis indicated the solvent preference of deionized water for 
standards and final reconstitution of sample (Figures 2-11).  This preference yielded to 
direct analysis of water samples and solid phase extraction with reconstitution with de-
ionized water.  The initial gradient table (Table 1) was derived from several sources (9, 
15- 17).  The method transfer from instrument PE-1, columns A-1 and K-1, to instrument 
AG-1, column A-2, required changes to the gradient table and flow (Table 4).  Figures 
12-14 indicate that the column A-2 dimensions decreased the retention time of the com-
ponents.  Changes made to the gradient table enabled the acetaminophen peak to be re-
tained on the column thereby separating it from the solvent front.   
The packing of the three columns incorporated the fused core technology.    Sta-
tionary phase is bound to the porous shell that covers the solid core particles decrease the 
                                                     
7 Results are corrected due to blank. 
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dispersion as the analyte travels in the column, Eddy diffusion (18, 19).  The decrease in 
the Eddy diffusion impacts Van Deemters equation for plate height (19): 
ܪܧܶܲ ൌ ܣ ൅ ܤݑ ൅ ܥݑ 
HETP = Height equivalent to theoretical plate 
A = Eddy Diffusion 
B= Longitudinal diffusion 
C= Resistance to mass transfer 
ݑ= average velocity of mobile phase 
 
Use of the fused core columns increase plates, minimizes peak broaden, decrease analysis 
time and decrease mobile phase.  PPCP mix standard at 0.02ppm had signal to noise lev-
els(S:N) above 3, (detection limit8).  Standards at 0.025ppm had S:N levels above 10, 
(quantitation limit8).  Although the linearity at the lower standard concentrations yielded 
values ≥ 0.999 for all PPCPs, the recoveries indicated a bias at this level.   
Solid phase extractions were conducted with Restek Resprep C18 and Waters Oa-
sis HLB cartridges.  Both cartridges lacked retention for acetaminophen. Analysis con-
ducted with the Restek cartridge improved in recoveries as the sample load (PPCP solu-
tion) increased for caffeine, and bisphenol.  Triclosan at 2ppm had the best recovery.  
Solid phase extraction with the Waters Oasis HLB had recoveries of 100% ± 20% for 
caffeine, Bisphenol-A, and Triclosan for 0.05 spiked water samples.  Mass spectrums in-
dicated m/z ratios for the four PPCP in the 0.025ppm mix at very low intensities.  Mass 
spectrums for 0.0005ppm PPCP mix (C) (Waters Oasis HLB 0.0005 ppm SPE) exhibited 
m/z ratios for caffeine, bisphenol-A and triclosan, Figures 17-19. At higher concentra-
tions, the both cartridges retained acetaminophen; however the recoveries were ≤ 20%. 
 
                                                     
8 Industry Standards 
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Figure 17: Mass Spectrum Oasis HLB 0.0005ppm Mix Caffeine 
 
 
  Caffeine, m/z 195.2, (negative mode) Spectrum Enlarged 
 
  Figure 18: Mass Spectrum Oasis HLB 0.0005ppm Mix Bisphenol-A 
 
 Bisphenol-A, m/z 227.3, (negative mode) 
 
Figure 19: Mass Spectrum Oasis HLB 0.0005ppm Mix Triclosan 
 
 Triclosan, m/z 289.1, (negative mode) 
CHAPTER 6 CONCLUSION 
 
 The detection of pharmaceuticals and personal care products in water samples can 
be achieved using the methods, instruments and columns outlined in this paper.   
Detection of PPCPs, caffeine, bisphenol-A, and triclosan, on water samples with 
concentrations ≥ 0.05ppm (50ng/mL) can be achieved using solid phase extraction with 
Oasis HLB cartridges. Oasis HLB solid phase extraction on 0.0005ppm PPCP mix was 
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inconclusive.   Three replicates had positive results for caffeine, bisphenol-A and triclo-
san.  The results however did not correlate with each other indicating that further work is 
required to improve the quantitation of caffeine, bisphenol-A and triclosan in water sam-
ples.   
Non detection of acetaminophen on Restek Resprep, and on Oasis HLB indicates 
that the procedures outlined in this paper are not suitable for acetaminophen.  Further 
studies of acetaminophen retention on solid phase extraction are required.  Acetamino-
phen detection is possible on direct injections of water samples on concentrations of 
0.02ppm and higher. 
 Quantitation of pharmaceuticals and personal care products in water samples can 
be achieved with standards between 0.2 and 10ppm.  Standards at lower concentration 
indicated a bias in the recoveries by 7% for acetaminophen, 15% for bisphenol-A, 12% 
for triclosan and 30% for caffeine. This bias in quantitation indicated more work required 
to improve the recoveries at the PPCP levels below 0.05ppm.   
 This method can be applied to surface water samples for detection of acetamino-
phen, caffeine, bisphenol-A and triclosan as a direct injection of with sample clean up 
using solid phase extraction.  Actual analysis of surface water samples will occur in the 
next phase of this project. 
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